Renal Cancer - Results from #5260

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients April 3, 2017

Urologic Oncologic Survey Robotic level III inferior vena cava tumor thrombectomy: Initial series. April 3, 2017

Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. April 2, 2017

Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a April 1, 2017

Interconnection: A qualitative analysis of adjusting to living with renal cell carcinoma April 1, 2017

Final overall survival analysis for the phase II RECORD-3 Study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC March 31, 2017

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma March 31, 2017

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma March 31, 2017

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study March 30, 2017

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival March 30, 2017

Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL EFFECT Trial March 30, 2017

Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas March 30, 2017

Differentiating Renal Neoplasms From Simple Cysts on Contrast-Enhanced CT on the Basis of Attenuation and Homogeneity March 30, 2017

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical t March 29, 2017

Percutaneous biopsy of the renal mass: FNA or core needle biopsy? March 29, 2017

IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells March 29, 2017

Diagnostic Criteria for Oncocytic Renal Neoplasms: A Survey of Urologic Pathologists March 28, 2017

[Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?] March 28, 2017

Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. March 28, 2017

[When is cytoreductive nephrectomy not beneficial for patients with metastatic renal cell carcinoma?] March 28, 2017

Page 264 of 456